ARCHIVES

Women’s Health Trial Committee Hears New Analysis Of Vanguard Groups, Other Data

This article is from The Cancer Letter archive.

Vol. 14 No. 01 | January 1, 1988

Download PDF Visit The Full Archive

Related Articles

DCT Programs Status Reported to Board

July 5, 1985

Study Tests PARP Inhibitor ABT-888 For Several Cancers

September 25, 2009

Bisphosphonates May Reduce Recurrent Breast Cancer

December 25, 2009

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

In Brief: Kennedy Drops Health Care Institute Plan Senate Approves Dole Amendment On Patents

August 18, 1978

2015: “A Challenge For Our Generation,” AACR Says

July 18, 2003